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Abstract: A concise synthetic route leading to highly functional erythrina alkaloid skeletons has been developed. The key process 
is an oxidative carbon-carbon coupling followed by a conjugated addition. Based on this new strategy, a formal synthesis of  
demethoxyerythratidinone was completed in only 6 steps from 4-aminophenol. 
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Introduction 
The genus Erythrina is widely distributed in tropical and 
subtropical regions and has been used in indigenous  
medicine.1 Erythrina alkaloids are common constitutes isolated 
from this species. Representative structures of the erythrina 
alkaloid family are characterized by a tetracyclic ring system 
and featured with an 1-azaspiro[5.5]undecane unit (Figure 1). 
A variety of biological effects are associated with the erythrina 
skeleton including sedative, hypotensive, neuromuscular 
blocking and CNS activity.1a,2 Because of its typical structure 
and interesting bioactivities, there has been much interest in 
the synthesis of these alkaloids and derivatives over the years.3 
An impressive strategy towards erythrina skeleton is  
biomimetic approach through an oxidative carbon-carbon bond 
formation.4 Although numerous imaginative synthetic routes 
have been developed based on the oxidative coupling,5 few 
meet adequate measures of flexibility and efficiency in terms 
of diversity oriented synthesis. 
We recently initiated a research program towards the  
synthesis of structurally diverse compounds by using oxidative 
formation of carbon-carbon bond as the key reaction. The spiro
cyclohexyldienonyl -lactams, oxindoles and structural unit 
for erythrina alkaloids were synthesized from the amide  
derivatives of 4-aminophenol.6 In this paper, we reported the 
results towards the synthesis of analogues of erythrina alkaloids.  
 
Results and Discussion 
The retrosynthetic analysis is showed in Scheme 1. Starting 
from the commercially available 4-aminophenol (1kg/157USD),
we speculated that a highly functional erythrina skeleton could 
be reached by a sequential oxidative dearomatization and a 
Michael addition. 
We began our research by an amidation of 4-aminophenol 
(1) with homoveratroyl chloride (2).7 The product, amide (3), 
was then converted to amine by a reduction with lithium 
aluminium hydride in THF (83%). By treatment of amine (4) 
with ethyl 3-chloro-3-oxopropanoate in dichloromethane in 
the presence of pyridine, amide (5) was obtained in 71% yield 
over three steps. Other amides (10 and 11), aiming at the 
synthesis of erythraline and its analogues, were prepared in 
three or four steps by the same procedure as shown in  
Scheme 2. 
Figure 1.  Representative erythrina alkaloids. 
 





















X = H,H; X = O  
Scheme 1.  Retrosynthetic analysis of the erythrina alkaloids. 
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The key oxidative coupling process was attempted by 
treatment of amide (5) with iodobenzene diacetate (IBD) in 
methanol, a well-established dearomatization procedure.8 To 
our disappointment, this oxidative condition only led to 
cyclohexyldienone (12). We then tried the oxidation with 
(bis(trifluoroacetoxy)iodo) benzene (PIFA) in trifluoroethanol 
at 40C.9 To our delight, this oxidation provided the desire 
azaspiro cyclohexyldienone (13), after treatment with DBU in 
dichloromethane, the desire intermediate (14) with a highly 
functional erythrina skeleton was obtained in 72% yield. This 
two steps procedure was soon optimized to be an efficient 
“one-pot” reaction: after the oxidative coupling, potassium 
carbonate was directly introduced to the reaction mixture at 
room temperature, and compound 14 was obtained in 83% 
isolated yield. Although oxidative coupling of amides 10 and 
11 proceeded under the same reaction condition, the yield 
(70% and 72% for 15 and 16) was relatively lower than that of 
amide 5, possibly due to the poor electron donating ability 
imposed by stereoelectronic effect of the methylenedioxy 
substituent.10 This one-pot cyclization furnished the highly 
functional erythrina skeletons in an efficient way (4 steps for 
erythrina derivative 14 and 4~5 steps for erythrina derivatives 
15 and 16). 
Having successfully constructed the azaspiro cyclohexyl-
dienone, we turned our attention next to convert compound 14 
to the natural product, namely 3-demethoxyerythratidinone. 
Compound 14 was further manipulated, hydrogenation 
followed by decarboxylation, to a known intermediate for the 
synthesis of demethoxyerythratidinone (Scheme 4), thus 
furnished a formal synthesis of this natural erythrina 
alkaloid.11 
In conclusion, we have developed a practical and efficient 
method for the synthesis of erythrina skeletons. Based on this 
methodology, a formal synthesis of demethoxyerythratidinone 
was also completed. The highly functional erythrina 
derivatives could be used not only as intermediates for the 
synthesis of natural erythrina alkaloids but also be used as 

























































































































































10 R = OEt
11 R = Me




15 R = OEt (70%)
16 R = Me (72%)  
Scheme 3.  Concise synthesis of erythrina skeletons. 
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Experimental Section 
General Experimental Procedures. Melting points were 
obtained on a XT-4 melting-point apparatus and were  
uncorrected. Proton nuclear magnetic resonance (1H NMR) 
spectra were recorded on a Bruker Avance 300 spectrometer at 
300 MHz. Carbon-13 nuclear magnetic resonance (13C NMR) 
was recorded on Bruker Avance 300 spectrometer at 75 MHz. 
Chemical shifts are reported as δ values in parts per million 
(ppm) relative to tetramethylsilane (TMS) for all recorded 
NMR spectra. Low-resolution mass spectra were recorded on a 
VG Auto Spec-3000 magnetic sector MS spectrometer. High 
resolution mass spectra were taken on AB QSTAR Pulsar 
mass spectrometer. Silica gel (200–300 mesh) for column 
chromatography and silica GF254 for TLC were produced by 
Qingdao Marine Chemical Company (China). All air- or  
moisture-sensitive reactions were conducted under an argon 
atmosphere. Starting materials and reagents used in reactions 
were obtained commercially from Acros, Aldrich, Fluka and 
were used without purification, unless otherwise indicated. 
 
Synthesis of Compound 3. To a solution of 4-aminophenol 
(1, 546 mg, 5 mmol) in CH2Cl2 (20 mL) and pyridine (2.02 
mL, 25 mmol, 5.0 eq.) at 0°C, homoveratroyl chloride (2, 5.5 
mmol, 1.1 eq.) in dichloromethane (5 mL) was added  
dropwise. The resulting mixture was then stirred at room  
temperature for 3–4 h. The reaction mixture was diluted with 
CH2Cl2 (20 mL) and treated with 2N HCl (10 mL) for 10 min 
and the aqueous phase was separated and the organic phase 
was washed with water (2 × 15 mL). After dried over  
anhydrous Na2SO4 and filtration, the solvent was removed 
under reduced pressure and the residue (1.43 g) was used in 
next step without further purification. 
 
Synthesis of Compound 4. To a solution of 3 (1.43 g) in 
anhydrous THF (50 mL) at 0°C, LiAlH4 (380 mg, 10 mmol, 
2.0 eq.) was added in one portion. The resulting mixture was 
gradually warmed up to room temperature then stirred at 75°C 
overnight. The reaction mixture was cooled to 0°C and an 
aqueous solution of saturated K2CO3 (5 mL) was added  
dropwise. The mixture was diluted with water (50 mL) and 
extracted with EtOAc (3 × 15 mL). The organic phases were 
combined and washed with water (2 × 15 mL) and brine (15 
mL). After dried over anhydrous Na2SO4 and filtration, the 
solvent was removed under reduced pressure and the residue 
was chromatographed on silica gel (CH2Cl2 : EtOAc = 15:1) to 
afford amine 4 (984 mg, 72% over two steps). Pale yellow 
syrup, 1H NMR (300 MHz, CD3COCD3) δ: 6.82 (1H, d, J = 
8.1 Hz), 6.80–6.63 (4H, m), 6.54 (2H, d, J = 8.4 Hz), 3.85 (3H, 
s), 3.84 (3H, s), 3.32 (1H, t, J = 6.6 Hz), 2.83 (1H, t, J = 6.6 
Hz). 13C NMR (75 MHz, CD3COCD3) δ: 148.98, 148.71, 
147.60, 141.46, 131.86, 120.78, 116.36, 115.43, 112.16, 
111.52, 55.96, 55.87, 46.61, 34.93. HRESIMS m/z found: 
274.1437, calcd. for C16H20NO3 [M + H]+: 274.1443. 
 
Synthesis of Compound 5. To a solution of 4 (820 mg, 3 
mmol) in CH2Cl2 (30 mL) and pyridine (1.21 mL, 15 mmol, 
5.0 eq.) at 0°C, ethyl 3-chloro-3-oxopropanoate (496 mg, 3.3 
mmol, 1.1 eq.) in CH2Cl2 (3 mL) was added dropwise. The 
resulting mixture was then stirred at room temperature for 2–3 
h. The reaction mixture was then treated with 2N HCl (10 mL) 
for 10 min and diluted with CH2Cl2 (20 mL). The aqueous 
phase was separated and the organic phase was washed with 
water (2 × 3 mL). The organic phases were combined and back 
extracted with EtOAc (10 mL). The combined organic phases 
were dried over anhydrous Na2SO4 and filtration. After  
removal of the solvent under reduced pressure, the residue was 
chromatographed on silica gel (Hexane : EtOAc = 4:1–2:1) to 
afford amides 5 (815 mg, 70%). Pale yellow powder, m.p.: 
138–139ºC. 1H NMR (300 MHz, CDCl3) δ: 6.93 (2H, d, J = 
8.7 Hz), 6.90 (2H, d, J = 8.7 Hz), 6.75 (1H, d, J = 7.8 Hz), 
6.74 (1H, d, J = 1.5 Hz), 6.68 (1H, dd, J = 7.8, 1.5 Hz), 4.10 
(2H, q, J = 7.2 Hz), 3.89 (2H, t, J = 7.9 Hz), 3.81 (6H, s), 3.20 
(2H, s), 2.83 (2H, t, J = 7.9 Hz), 1.20 (3H, t, J = 7.2 Hz). 13C 
NMR (75 MHz, CDCl3) δ: 167.97, 167.14, 157.11, 148.97, 
147.64, 133.75, 131.09, 129.17, 120.87, 116.73, 112.22, 
111.42, 61.51, 55.98, 55.92, 51.50, 41.90, 33.37, 14.09. 
HRESIMS m/z found: 388.1759, calcd. for C21H26NO6 [M + 
H]+: 388.1760. 
 
Synthesis of Compounds 8 and 9. The procedures were 
same as compounds 3 and 4. Compound 8 (52%): Pale yellow 
syrup. 1H NMR (300 MHz, CD3COCD3) δ: 6.59 (1H, d, J = 
8.1 Hz), 6.55–6.51 (4H, m), 6.34 (2H, d, J = 8.4 Hz), 5.76 (2H, 
s), 3.12 (1H, t, J = 6.9 Hz), 2.64 (1H, t, J = 6.9 Hz), 0.83 (9H, 
s), 0.00 (9H, s). 13C NMR (75 MHz, CD3COCD3) δ: 147.82, 
1447.54, 146.12, 142.54, 133.19, 121.66, 120.71, 114.20, 
109.12, 108.32, 100.87, 46.11, 35.37, 25.79, 18.20, −4.50. 
HRESIMS m/z found: 371.1925, calcd. for C21H29NO3Si [M]+: 
371.1917. Compound 9 (33%): Pale yellow syrup, 1H NMR 
(300 MHz, CD3COCD3) δ: 6.75 (1H, d, J = 7.8 Hz), 6.70–6.63 
(4H, m), 6.53 (2H, d, J = 8.7 Hz), 5.93 (2H, s), 3.29 (1H, t, J = 
6.9 Hz), 2.80 (1H, t, J = 6.9 Hz). 13C NMR (75 MHz, 
CD3COCD3) δ: 147.97, 148.80, 146.11, 142.05, 133.08, 
121.65, 116.25, 114.77, 109.09, 108.32, 100.86, 46.35, 35.25. 
HRESIMS m/z found: 257.1057, calcd. for C15H15NO3 [M]+: 
257.1052. 
 
Synthesis of Compound 10. To a solution of 8 (557 mg, 
1.5 mmol) in CH2Cl2 (20 mL) and pyridine (0.6 mL, 7.5 mmol, 
5.0 eq.) at 0°C, ethyl 3-chloro-3-oxopropanoate (248 mg, 1.65 

































Scheme 4.  Formal synthesis of erythrina alkaloid  
  demethoxyerythratidinone. 
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resulting mixture was then stirred at room temperature for 2–3 
h. The reaction mixture was then treated with 2N HCl (10 mL) 
for 10 min and diluted with CH2Cl2 (20 mL). The aqueous 
phase was separated and the organic phase was washed with 
water (2 × 3 mL). The organic phases were combined and back 
extracted with EtOAc (10 mL). The combined organic phases 
were dried over anhydrous Na2SO4 and filtration. Then  
removal of the solvent under reduced pressure and dissolved in 
dry THF (20 mL). To the solution was added TBFA (1.0 M 
solution in THF, 1.5 mL, 1.5 mmol) under argon. The reaction 
mixture was stirred at room temperature for 2 h. The mixture 
was concentrated and diluted with water (30 mL) and extracted
with EtOAc (3 × 15 mL). The organic phases were combined 
and washed with water (2 × 15 mL) and brine (15 mL). After 
dried over anhydrous Na2SO4 and filtration, the solvent was 
removed under reduced pressure and the residue was  
chromatographed on silica gel (Hexane : EtOAc = 4:1–2:1) to  
afford amine 10 (512 mg, 92% over two steps). Pale yellow 
powder. 1H NMR (300 MHz, CDCl3) δ: 8.10 (1H, s), 7.00 (2H, 
d, J = 8.7 Hz), 6.94 (2H, d, J = 8.7 Hz), 6.68 (1H, d, J = 7.8 
Hz), 6.65 (1H, d, J = 1.2 Hz), 6.60 (1H, dd, J = 1.2, 7.8 Hz), 
5.88 (1H, s), 4.12 (2H, q, J = 8.1 Hz), 3.86 (2H, t, J = 8.4 Hz), 
3.23 (2H, s), 2.81 (2H, t, J = 8.1 Hz), 1.25 (3H, t, J = 7.2 Hz). 
13C NMR (75 MHz, CDCl3) δ: 167.91, 167.19, 157.11, 147.64, 
146.09, 133.58, 132.12, 129.01, 121.68, 116.75, 109.22, 
108.22, 100.81, 61.47, 51.66, 41.79, 33.45, 14.01. HRESIMS 
m/z found: 371.1369, calcd. for C20H21NO6 [M]+: 371.1369. 
 
Synthesis of Compound 11. To a solution of 9 (386 mg, 
1.5 mmol) in toluene (20 mL) 2,2,6-trimethyl-1,3-dioxin-4-one 
(213 mg, 1.5 mmol) in toluene (5 mL) was added  
dropwise. The resulting mixture was then stirred at reflux 
overnight. The mixture was concentrated and the residue was 
chromatographed on silica gel (Hexane : EtOAc = 4:1–2:1) to 
afford amine 11 (423 mg, 90%). Pale yellow powder. 1H NMR 
(300 MHz, CDCl3) δ: 7.91 (1H, s), 6.95 (2H, d, J = 8.7 Hz), 
6.91 (2H, d, J = 8.7 Hz), 6.72 (1H, d, J = 8.1 Hz), 6.66 (1H, d, 
J = 1.2 Hz), 6.61 (1H, dd, J = 1.2, 8.1 Hz), 5.91 (1H, s), 3.87 
(2H, q, J = 7.8 Hz), 3.33 (2H, s), 2.81 (2H, t, J = 7.8 Hz), 2.06 
(3H, s). 13C NMR (75 MHz, CDCl3) δ: 202.64, 167.77, 156.90, 
147.65, 146.09, 133.82, 132.13, 129.09, 121.70, 116.70, 
109.23, 108.23, 100.82, 51.39, 50.13, 33.52, 30.33. HRESIMS 
m/z found: 341.1259, calcd. for C19H19NO5 [M]+: 341.1263. 
 
Synthesis of Compound 14. To a solution of 5 (387 mg, 
1.0 mmol) in CF3CH2OH (3 mL) was added PIFA (473 mg, 
1.1 mmol, 1.1 eq.) at −40°C under N2. After stirring at −40°C 
for 2 h, the reaction mixture was allowed to warm to room 
temperature then a powder of K2CO3 (456 mg, 3.3 mmol, 3.3 
eq.) was added. The resulting mixture was filtered and washed 
with EtOAc (10 mL). The filtrate was concentrated and the 
crude products were chromatographed on silica gel (CH2Cl2 : 
EtOAc = 10:1) to provide enone 14 (318 mg, 83%). White 
crystals, m.p.: 161–162ºC. 1H NMR (300 MHz, CDCl3) δ: 
6.71 (1H, dd, J = 10.5, 1.8 Hz), 6.67 (1H, s), 6.65 (1H, s), 6.18 
(1H, d, J = 10.2 Hz), 4.41 (1H, dd, J = 12.0, 3.9 Hz), 4.30–
4.21 (2H, m), 3.87 (3H, s), 3.79 (3H, s), 3.39 (1H, d, J = 11.7 
Hz), 3.21 (1H, dd, J = 12.1, 5.7 Hz), 3.20–2.93 (3H, m), 2.72 
(1H, d, J = 12.9 Hz), 2.66 (1H, d, J = 12.9 Hz ), 1.27 (3H, t, J 
= 7.2 Hz). 13C NMR (75 MHz, CDCl3) δ: 195.07, 168.29, 
166.65, 149.23, 148.49, 145.79, 127.65, 126.75, 126.30, 
112.79, 108.77, 62.19, 59.49, 56.36, 56.09, 54.03, 44.45, 
36.69, 35.73, 29.03, 14.29. HRESIMS m/z found: 386.1599, 
calcd. for C21H24NO6 [M + H]+: 386.1603. 
 
Synthesis of Compounds 15 and 16. The procedures were 
same as compound 14. Compound 15 (70%): Pale yellow  
syrup. 1H NMR (300 MHz, CDCl3) δ: 6.69 (1H, dd, J = 10.2, 
1.8 Hz), 6.67 (1H, s), 6.66 (1H, s), 6.17 (1H, d, J = 10.2 Hz), 
5.96 (2H, s), 4.40 (1H, dd, J = 12.0, 3.9 Hz), 4.31–4.20 (2H, 
m), 3.38 (1H, d, J = 11.7 Hz), 3.21 (1H, m), 3.13–2.89 (3H, 
m), 2.70 (1H, d, J = 12.9 Hz), 2.65 (1H, d, J = 12.9 Hz ), 1.31 
(3H, t, J = 7.2 Hz). 13C NMR (75 MHz, CDCl3) δ: 194.82, 
168.17, 166.51, 147.64, 147.17, 145.38, 127.81, 126.64, 
127.31, 109.85, 105.57, 101.47, 62.07, 59.63, 53.89, 44.39, 
36.34, 35.54, 29.46, 14.15. HRESIMS m/z found: 369.1220, 
calcd. for C20H19NO6 [M]+: 369.1220. Compound 16 (72%): 
Pale yellow syrup. 1H NMR (300 MHz, CDCl3) δ: 6.71 (1H, s), 
6.68 (1H, dd, J = 10.2, 1.8 Hz), 6.45 (1H, s), 6.15 (1H, d, J = 
10.2 Hz), 5.95 (2H, s), 4.34 (1H, dd, J = 12.0, 3.9 Hz), 3.48 
(1H, d, J = 11.4 Hz), 3.30–3.24 (1H, m), 3.13–3.01 (2H, m), 
2.88 (1H, ddd, J =16.8, 12.3, 5.1 Hz), 2.69 (1H, dd, J = 15.9, 
2.1 Hz), 2.54 (1H, d, J = 18.3 Hz ), 2.47 (3H, s). 13C NMR (75 
MHz, CDCl3) δ: 201.74, 195.45, 166.55, 147.58, 147.18, 
145.65, 127.68, 127.49, 109.74, 105.55, 101.45, 59.87, 59.13, 
41.48, 36.72, 35.42, 30.97, 29.37. HRESIMS m/z found: 
339.1104, calcd. for C19H17NO5 [M]+: 339.1104. 
 
Synthesis of Compound 17. To a solution of 13 (385.4 mg, 
1.0 mmol) in anhydrous EtOH (20 mL) was added a powder of 
10% Pd/C (38 mg). The resulting mixture was then stirred at 
room temperature under a balloon of hydrogen overnight.  
After fitration and washed with CH2Cl2 (5 mL), the filtrate 
was concentrated and the residue was chromatographed on 
silica gel (CH2Cl2 : EtOAc = 5:1–3:1) to afford ketone 17 (368 
mg, 95%). White plates, m.p.: 182–183ºC. 1H NMR (300 MHz, 
CDCl3) δ: 6.68 (1H, s), 6.56 (1H, s), 4.34 (1H, dd, J = 13.2, 
5.4 Hz), 4.15 (2H, q, J = 7.2 Hz), 3.86 (3H, s), 3.84 (3H, s), 
3.44–3.34 (1H, m), 3.18 (1H, d, J = 8.1 Hz), 3.15–2.90 (2H, 
m), 2.65 (1H, d, J = 16.8 Hz), 2.64 (1H, d, J = 16.8 Hz), 2.49–
2.20 (4H, m), 1.22 (3H, t, J = 7.2 Hz). 13C NMR (75 MHz, 
CDCl3) δ: 209.23, 169.01, 167.18, 148.71, 148.54, 133.87, 
125.48, 111.94, 107.36, 62.16, 61.47, 56.44, 56.03, 55.21, 
42.55, 42.06, 35.62, 35.44, 33.50, 27.82, 14.14. HRESIMS m/z 
found: 388.1751, calcd. for C21H26NO6 [M + H]+: 388.1760. 
 
Synthesis of Compound 18. A mixture of 17 (193 mg, 0.5 
mmol.), LiCl (21 mg, 0.5 mmol, 1.0 eq.) and H2O (27 mg, 1.5 
mmol, 3.0 eq.) in DMSO (15 mL) was stirred at 158°C under 
N2 overnight (ca. 15–17 h). The resulting mixture was then 
concentrated under reduced pressure and the residue was 
chromatographed on silica gel (CH2Cl2 : EtOAc = 3:1–2:1) to 
afford 18 (118 mg, 75%). Pale yellow powder, m.p.: 164–
165ºC. 1H NMR (300 MHz, CDCl3) δ: 6.68 (1H, s), 6.56 (1H, 
s), 4.37 (1H, dd, J = 12.0, 5.4 Hz), 3.86 (3H, s), 3.84 (3H, s), 
3.15–2.90 (4H, m), 2.78–2.53 (3H, m), 2.49–2.20 (4H, m), 
2.11 (1H, dd, J = 17.8, 7.5 Hz). 13C NMR (75 MHz, CDCl3) δ: 
210.13, 172.19, 148.60, 148.43, 134.48, 125.65, 111.91, 
107.45, 62.56, 56.45, 56.03, 43.38, 37.90, 37.59, 35.35, 34.84, 
33.64, 27.67. HRESIMS m/z found: 316.1556, calcd. for 
C18H22NO4 [M + H]+: 316.1548. 
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